Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents

Primary series vaccination with BNT162b2 followed by a booster 5 months later has been recommended for healthy adolescents. We aimed to describe the immunogenicity in a fractional dose of BNT162b2. Adolescents aged 12–18 years were randomized into six arms for primary series administration: 3wPZ30/3...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthanakit, Thanyawee, Chantasrisawad, Napaporn, Yoohat, Kirana, Nantanee, Rapisa, Sophonphan, Jiratchaya, Meepuksom, Thutsanun, Sodsai, Pimpayao, Phanthanawiboon, Supranee, Jantarabenjakul, Watsamon, Hirankarn, Nattiya, Kosalaraksa, Pope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609361/
https://www.ncbi.nlm.nih.gov/pubmed/36298510
http://dx.doi.org/10.3390/vaccines10101646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609361/
https://www.ncbi.nlm.nih.gov/pubmed/36298510
http://dx.doi.org/10.3390/vaccines10101646

Ejemplares similares